Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 13 | -423K | 100% | $95.89 | -$40.6M |
Net | -13 | -423K | -100% | -$40.6M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Jeffrey W. Albers | Director | $18.8M | -$8.78M | -31.8% | Dec 19, 2024 |
Kate Haviland | Chief Executive Officer | $15.9M | -$1.36M | -7.85% | Nov 29, 2024 |
Alexis Borisy | Director | $7.87M | Jun 12, 2024 | ||
Christina Rossi | Chief Operating Officer | $7.15M | -$985K | -12.1% | Dec 18, 2024 |
Fouad Namouni | President, R & D | $6.62M | -$721K | -9.83% | Oct 3, 2024 |
Michael Landsittel | Chief Financial Officer | $6.4M | -$4.02M | -38.6% | Aug 15, 2024 |
Nicholas Lydon | Director | $6.17M | Jun 12, 2024 | ||
Percy H. Carter | Chief Scientific Officer | $5.87M | -$887K | -13.1% | Jul 1, 2024 |
Tracey L. McCain | Evp And Chief Legal Officer | $5.86M | -$471K | -7.44% | Mar 7, 2024 |
Debra Durso-Bumpus | Chief People Officer | $4.87M | -$9.62M | -66.4% | Jul 3, 2024 |
Christopher K. Murray | Chief Technical Operations | $3.45M | -$787K | -18.6% | Mar 7, 2024 |
L. Becker Hewes | Chief Medical Officer | $3.39M | -$4.67M | -58% | Jun 4, 2024 |
Philina Lee | Chief Commercial Officer | $3.24M | -$4.9M | -60.2% | Aug 5, 2024 |
Mark Alan Goldberg | Director | $1.99M | Jun 12, 2024 | ||
Lynn Seely | Director | $1.46M | Jun 12, 2024 | ||
Ariel Hurley | Principal Accounting Officer | $1.41M | -$1.52M | -51.9% | Dec 12, 2024 |
Daniella Beckman | Director | $1.21M | Jun 12, 2024 | ||
Habib J. Dable | Director | $988K | Jun 12, 2024 | ||
John Tsai | Director | $988K | Jun 12, 2024 | ||
George Demetri | Director | $837K | Jun 21, 2022 | ||
Charles A. Rowland Jr | Director | $591K | Jun 2, 2021 | ||
Tango Therapeutics, Inc. | Director | $411K | Dec 8, 2021 | ||
Lonnel Coats | Director | $261K | -$1.87M | -87.8% | Nov 20, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|